Nucleic Acids Research, Vol 25, Issue 8 1585-1590, Copyright © 1997 by Oxford University Press
C Souriau, P Fort, P Roux, O Hartley, MP Lefranc and M Weill
Studies on receptor-ligand interactions are important for the design of
agonists or antagonists of natural ligands. We developed a luciferase
reporter assay to screen epidermal growth factor receptor (EGFR) binding
molecules rapidly for their ability to stimulate or inhibit signal
transduction. Human EGF displayed on fd filamentous phage presented an
activity similar to soluble EGF when tested for binding to the EGFR, for
induction of cell cycle progression or in the luciferase assay. Two
libraries of human EGF variants displayed on phage were constructed in
which the aspartic acid residue at position 46 or the arginine residue at
position 41 were randomised. EGF mutants displayed on phage were screened
in parallel for binding to the EGFR using an ELISA assay and for
transducing activity using the luciferase assay. Regarding the 46 position,
most of the mutants retained the ability to bind the EGFR and their
transducing activity corresponded perfectly with their binding. For the
more crucial 41 position, only the wild- type EGF was able to bind the
EGFR. Our approach allowed a simple determination of crucial positions and
paved the way for identification of agonists with altered transduction
activity.
ARTICLES
A simple luciferase assay for signal transduction activity detection of epidermal growth factor displayed on phage
Institut de Genetique Moleculaire, UMR CNRS 5535, BP5051, 1919 Route de Mende, 34033 Montpellier cedex 1, France.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. R. Cochran, Y.-S. Kim, S. M. Lippow, B. Rao, and K.D. Wittrup Improved mutants from directed evolution are biased to orthologous substitutions Protein Eng. Des. Sel., June 1, 2006; 19(6): 245 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bach, P. Holig, E. Schlosser, T. Volkel, A. Graser, R. Muller, and R. E. Kontermann Isolation from phage display libraries of lysine-deficient human epidermal growth factor variants for directional conjugation as targeting ligands Protein Eng. Des. Sel., December 1, 2003; 16(12): 1107 - 1113. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stortelers, S. P. van der Woning, S. Jacobs-Oomen, M. Wingens, and E. J. J. van Zoelen Selective Formation of ErbB-2/ErbB-3 Heterodimers Depends on the ErbB-3 Affinity of Epidermal Growth Factor-like Ligands J. Biol. Chem., March 28, 2003; 278(14): 12055 - 12063. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. LAROCCA, P. D. KASSNER, A. WITTE, R. C. LADNER, G. F. PIERCE, and A. BAIRD Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage FASEB J, April 1, 1999; 13(6): 727 - 734. [Abstract] [Full Text] |
||||
![]() |
M. D. Ballinger, J. T. Jones, J. A. Lofgren, W. J. Fairbrother, R. W. Akita, M. X. Sliwkowski, and J. A. Wells Selection of Heregulin Variants Having Higher Affinity for the ErbB3 Receptor by Monovalent Phage Display J. Biol. Chem., May 8, 1998; 273(19): 11675 - 11684. [Abstract] [Full Text] [PDF] |
||||


